AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014
Jan 14, 2014
30583_dirs_2014-01-14_d5f41168-718a-49c0-9eee-18130425f045.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-01-10
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-10 | Common Stock | M | 5000 | $12.99 | Acquired | 55740 | Indirect |
| 2014-01-10 | Common Stock | S | 5000 | $70 | Disposed | 50740 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-10 | Stock Option (right to buy Common Stock) | $12.99 | M | 5000 | Disposed | 2016-05-10 | Common Stock (5000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Indirect |
| Common Stock | 10000 | Indirect |
| Common Stock | 10000 | Indirect |
| Common Stock | 10000 | Indirect |
| Common Stock | 20000 | Indirect |
Footnotes
F1: Transaction made pursuant to a Rule 10b5-1 trading plan executed on February 26, 2013.
F2: The reporting person and his spouse act as trustees for the Bienaime Family Trust.
F3: All shares sold at same price.
F4: The reporting person's spouse is trustee of each child's trust.
F5: Original option grant vests 6/48th on November 11, 2006, and 1/48th on the 11th day of every month thereafter
F6: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.